Stock Information
Syndax Pharmaceuticals Inc (SNDX)
Ticker Symbol: SNDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,185.91 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.3003
Revenue (TTM): $1.99 M
Dividend Yield: N/A%
ROE: -206.62%
Latest News
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Wed, May 6, 2026 4:01 PM
-
Syndax Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Tue, May 5, 2026 7:15 PM
-
Syndax (SNDX) Narrows Losses as Revuforj and Niktimvo Gain Traction - What’s Really Shifting?
Fri, May 1, 2026 11:12 PM
-
Barclays Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $37
Fri, May 1, 2026 11:34 AM
-
Syndax Pharmaceuticals Inc (SNDX) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...
Fri, May 1, 2026 7:18 AM
-
Syndax Pharmaceuticals Q1 Earnings Call Highlights
Fri, May 1, 2026 2:42 AM
Key Financials
Financial data not available
